FT-IR STUDY BETWEEN PROPRANOLOL HYDROCHLORIDE AND PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS IN PHYSICAL MIXTURE
Main Article Content
Abstract
Propranolol hydrochloride (propranolol HCl) is a nonselective β-adrenergic blocking agent widely used for hypertension, angina pectoris, and many other cardiovascular disorders treatment. Fourier transform infrared spectroscopy (FT-IR) is a simple, rapid, and inexpensive method that was used to predict the drug-excipients interactions. Base on their frequent use in preformulation six pharmaceutically acceptable excipients: lactose, magnesium stearate, talcum, corn starch, microcrystalline cellulose pH 102 (avicel® pH 102), and sodium starch glycolate (explotab®) were mixed with propranolol HCl using simple physical technique in an agate mortar with pestle for approximately 5 min. The mixture samples were prepared by mixing propranolol HCl and each pharmaceutically acceptable excipients in a ratio of 1:1, 1:2, and 1:3 w/w. The FT-IR spectra showed the main peaks of propranolol HCl at 3270-3209, 2962-2715, 1250, and 802 cm-1 were secondary of hydroxyl group, secondary of amine group, aryl alkyl ether, and substituted naphthalene, respectively. Propranolol HCl and pharmaceutically acceptable excipients had not been interacting in their physical mixtures. The increasing of amount ratio of pharmaceutically acceptable excipients obviously increased the intensity of main peak of each pharmaceutically acceptable excipients around 1600-1000 cm-1.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Journal of TCI is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence, unless otherwise stated. Please read our Policies page for more information.
References
Amores, S, Domenech, J, Colom, H, Calpena, AC, Clares, B, Gimeno, Á and Lauroba, J. 2014. An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion cells. Eur. J. Pharm. Sci., 60: 49-54.
Bernardi, LS, Oliveira, PR, Murakami, FS, Silva, MAS, Borgmann, SHM and Cardoso, SG. 2009. Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients. J. Therm. Anal. Calorim., 97: 729-733.
Cid, E, Mella, F, Lucchini, L, Cárcamo, M and Monasterio, J. 1986. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharm Drug Dispos., 7: 559-566.
Fathima, N, Mamatha, T, Qureshi, HK, Anitha, N and Rao, JV. 2011. Drug-excipient interaction and its importance indosage form development. J Appl. Pharm. Sci., 1: 66-71.
Lira, AM, Araújo, AAS, Basílio, IDJ, Santos, BLL, Santana, DP and Macedo, RO. 2007. Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim. Acta, 457: 1-6.
Moreton, CR 2006. Excipient interactions. In: Katdare, A and Chaubal, MV (eds.) Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems. 1st ed. New York: Informa Healthcare USA, Inc.
Oliveira, PR, Bernardi, LS, Murakami, FS, Mendes, C and Silva, MAS. 2009. Thermal characterization and compatibility studies of norfloxacin for development of extended release tablets. J. Therm. Anal. Calorim., 97: 741-745.
Patel, V, Prajapati, B and Patel, M. 2007. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech, 8: E147-E154.
Thoorens, G, Krier, F, Leclercq, B, Carlin, B and Evrard, B. 2014. Microcrystalline cellulose, a direct compression binder in a quality by design environment—A review. Int. J. Pharm., 473: 64-72.
Tiţa, B, Fuliaş, A, Bandur, G, Marian, E and Tiţa, D. 2011a. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J. Pharm. Biomed. Anal., 56: 221-227.
Tiţa, B, Fuliaş, A, Szabadai, Z, Rusu, G, Bandur, G and Tiţa, D. 2011b. Compatibility study between ibuprofen and excipients in their physical mixtures. J. Therm. Anal. Calorim., 105: 517-527.
Tita, B, Ledeti, I, Bandur, G and Tita, D. 2014. Compatibility study between indomethacin and excipients in their physical mixtures. J. Therm. Anal. Calorim., 118: 1293-1304.
Tomassetti, M, Catalani, A, Rossi, V and Vecchio, S. 2005. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. J. Pharm. Biomed. Anal., 37: 949-955.